Journals / 7tepe Klinik / 2018 / Cilt: 14 - Sayı: 1

Role of resistin in chronic periodontitis

periodontitisteki rolü

Pages
87–92
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, studies on resistin level in CP will be discussed in detail

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Today adipose tissue is seen as a metabolically active and complex organ.
📊
Key Findings & Data:Resistin was first discovered in 2001 when investigating the effect of antidiabetic drugs on resistin gene expression.
💡
Conclusion & Impact:In this review, studies on resistin level in CP will be discussed in detail
🔬Design:Review & Systematic Survey
📍Scope:2001 Verileri
⚙️Variables:Domain Parameters

Abstract

Today adipose tissue is seen as a metabolically active and complex organ. It secretes a variety of bioactive substances such as resistin which is belonging to a cycteine-rich protein family. It is expressed in white adipose tissues in rodents and synthesized predominantly by immun cells such as mononuclear both within and outside adipose tissue in humans. Resistin derived its name from inducing insulin resistance (resist-in). Resistin was first discovered in 2001 when investigating the effect of antidiabetic drugs on resistin gene expression. Insulin, glucose, many cytokines and anti-diabetic thiazolidinediones are regulators of resistin gene expression. Studies suggest that increased resistin levels can be associated with the development of insulin resistance, obesity and type 2 diabetes mellitus (T2DM). In the presence of chronic periodontitis (CP), proinflammatory cytokines that cause destruction in periodontal tissues are responsible for the secretion of resistin and positive feedback mechanisms. Resistin would be one of the molecular links connecting CP and T2DM. But it is not yet possible to establish a direct causeand-effect relationship between resistin levels and chronic inflammatory diseases such as CP and T2DM. In this review, studies on resistin level in CP will be discussed in detail

Özet

Günümüzde adipoz doku metabolik açıdan aktif ve kompleks bir organ olarak görülmektedir. Sisteinden zengin protein ailesine ait olan resistin gibi birçok bioaktif molekül salgılamaktadır. Kemirgenlerde beyaz yağ dokusundan salgılanırken, insanlarda yağ dokusuyla birlikte bağışıklık kabiliyeti olan mononükleer hücreler tarafından da eksprese edilmektedir. Resistin ismi "resist insulin"den türetilmiş ve insülin direncinin uyarılması anlamına gelmektedir. Resistin ilk olarak 2001 yılında antidiyabetik ilaçların gen ekspresyonuna olan etkisi araştırılırken keşfedilmiştir. İnsülin, glukoz, birçok sitokin ve antidiyabetik bir ilaç olan tiazolidinedionların resistin gen ekspresyonunun düzenleyecisi olduğu ortaya konmuştur. Araştırmalar, artmış resistin düzeylerinin; insülin direnci, obezite ve tip 2 diabetes mellitus (T2DM) gelişimi ile ilişkili olduğunu düşündürmüştür. Kronik periodontitis (KP) varlığında, periodontal dokularda yıkıma sebep olan proenflamatuvar sitokinler resistinin salgılanmasından ve pozitif feedback mekanizmasından sorumludur. Resistinin, KP ve T2DM arasındaki ilişkiyi açıklayabilecek bir molekül olabileceğinin düşünülmesinin yanı sıra kısıtlı sayıda yapılan çalışmalarla KP ve T2DM gibi kronik enflamatuvar hastalıklarla resistin seviyesi arasında doğrudan bir neden sonuç ilişkisi kurabilmek henüz mümkün değildir. Bu derlemede, resistinin yapısına yönelik çalışmalarla beraber KP'de resistin seviyesinin incelendiği araştırmalar detaylı olarak ele alınacaktır

🔖

Cite This Article

DOĞAN, B., KALKAN, D. Y. (2018). Role of resistin in chronic periodontitis. 7tepe Klinik, Cilt: 14 - Sayı: 1, 87–92. https://ajindex.com/articles/149344

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Gimble JM. Adipose tissue-derived therapeutics. Expert Opin Biol Ther 2003; 3: 705-713
  2. Tilg H, Hotamisligil GS. Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance. Gastroenterology 2006; 131: 934-945
  3. Zhang Y, ve ark. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425- 432
  4. Housa D, Housova J, Vernerova Z, Haluzik M. Adipocy tokines and cancer. Physiol Res 2006; 55: 233-244
  5. Fukuhara A, ve ark. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science. 2005 307: 426-430
  6. Steppan CM, ve ark. The hormone resistin links obesity to diabetes. Nature 2001; 409: 307-312
  7. Wozniak SE, Gee LL, Wachtel MS, Frezza EE. Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci 2009; 54: 1847-1856
  8. Holcomb IN, ve ark. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 2000; 19: 4046-4055
  9. Liu T, ve ark. FIZZ2/RELM-β induction and role in pulmonary fibrosis. The Journal of Immunology 2011; 187: 450-461
  10. Rajala MW, Obici S, Scherer PE, Rossetti L. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest 2003; 111: 225-230
  11. Patel L, ve ark. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun. 2003; 300: 472-476
  12. Filkova M, Haluzik M, Gay S, Senolt L. The role of resistin as a regulator of inflammation: Implications for various human pathologies. Clin Immunol 2009; 133: 157- 170
  13. Gerstmayer B, ve ark. Identification of RELMgamma, a novel resistin-like molecule with a distinct expression pattern. Genomics 2003; 81: 588-595
  14. Bo S, ve ark. Relationships between human serum resistin, inflammatory markers and insulin resistance. Int J Obes (Lond). 2005 29: 1315-1320
  15. Kaser S, ve ark. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 2003; 309: 286-290
  16. Silswal N, ve ark. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun 2005; 334: 1092-1101
  17. Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005; 174: 5789-5795
  18. Kusminski CM, McTernan